A Phase I Study of PRO131921, a Novel Anti-CD20 Monoclonal Antibody in Patients with Relapsed/Refractory CD20+ Indolent NHL: Correlation Between Clinical Responses and AUC Pharmacokinetics.
| Autor: | Friedberg, Jonathan W., Vose, Julie M., Kahl, Brad S, Brunvand, Mark W., Goy, Andre, Kasamon, Yvette L., Burington, Bart *, Li, Jing *, Ho, William *, Cheson, Bruce D. |
|---|---|
| Zdroj: | In Blood 20 November 2009 114(22):3742-3742 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|